Category: Technology

Industry Update – Establishment of the Global Accreditation Cooperation

Posted on by Leave a comment

Establishment of the Global Accreditation Cooperation (GLOBAC)

The establishment of the Global Accreditation Cooperation (GLOBAC) marks a significant shift in the global accreditation landscape, merging the International Accreditation Forum (IAF) and the International Laboratory Accreditation Cooperation (ILAC) into a single entity.

This transition, aimed to be operational by January 2026, follows extensive discussions and agreements among IAF and ILAC members in 2024.

Key Developments

Formation of GLOBAC:

In 2019, IAF and ILAC members decided to create GLOBAC, which will take over their existing roles. The formal incorporation process began in New Zealand in October 2024 after the approval of GLOBAC’s Constitution and General Rules.

Mutual Recognition:

GLOBAC aims to enhance international trade by ensuring mutual recognition of accredited services across borders, thereby removing technical barriers. Until GLOBAC becomes operational, IAF and ILAC will continue their normal operations with existing recognition arrangements remaining valid

Transition Plan

Before Transition Date:

Until the Transition Date, IAF and ILAC will maintain their operations, and existing guidance for regulators will remain applicable. The IAF Multilateral Recognition Arrangement (IAF MLA) and ILAC Mutual Recognition Arrangement (ILAC MRA) will continue to function until GLOBAC takes over

After Transition Date:

Following the Transition Date, GLOBAC will assume all responsibilities of IAF and ILAC. Regulations referencing IAF MLA or ILAC MRA will gradually be updated to reflect GLOBAC’s framework. It is anticipated that the use of IAF MLA and ILAC MRA Marks will cease three years post-transition

Recommendations for Regulators:

Regulators are encouraged to collaborate with IAF and ILAC members to prepare for necessary changes in their documentation as GLOBAC becomes operational. This proactive approach will facilitate a smoother transition to the new accreditation framework

For further inquiries regarding this transition, stakeholders can contact the GLOBAC Executive Committee through its Secretary : secretary@globac.org

Click here to read more

Young Entrepreneurs Program (YEP)

Posted on by Leave a comment

Young Entrepreneurs Program (YEP) – YEP 2024

TiE Global is the largest non-profit organization devoted to entrepreneurs in all industries at all stages throughout the entrepreneurial lifecycle. Currently present in 61 chapters across 14 countries.

TiE Chennai is one of the best performing chapters committed to fostering entrepreneur ship through education, investing, incubation, mentoring and networking. TiE Chennai hosts various global initiatives

TiE Young Entrepreneurs (TYE)is a global program dedicated to fostering future generations of industry leaders by teaching high school students the rewards and challenges of becoming an entrepreneur. TYE is an “Entrepreneurship Academy,” where student teams utilize modern skills and tools to build a concept using customer feedback, iteration, and lightweight business models

Join the Young Entrepreneurs Program! (YEP) from TiE, Chennai

Develop your entrepreneurial skills with the Young Entrepreneurs Program (YEP), a program for students from Grades 8-12.

Wth Young Entrepreneurs Program (YEP) students can start on the entrepreneurship pathway to their professional careers. Programs like these are designed to prepare aspiring, future entrepreneurs who will emerge as strong as thought leaders, industry experts and community builders to create a more collaborative and innovative society.

Program Details:

Start Date: Saturday, November 16, 2024
End Date: Sunday, December 1, 2024

Eligibility 

Program for Students from Grades 8-12

Class Schedule:

Every Saturday: 4:30 PM to 7:30 PM
Every Sunday: 10:00 AM to 1:00 PM

Location:

Classroom No. 208, 2nd floor, Technology Tower, VIT Vellore

Fee : ₹4,000/- (Plus 18% GST)

For More Details and Registration, please Contact :

Mr Vidur Davey
Mobile: +91 8939882144
Email: vidur@tiechennai.org

Visit – https://events.tie.org/YoungEntrepreneurshipProgramYEP

Click here to read the Program Brochure

Industry Update – World Health Innovation Forum 2024

Posted on by Leave a comment

World Health Innovation Forum 2024 @ Vizag

Kalam Institute of Health Technology (KIHT), Vizag is organising the 2nd edition of World Health Innovation Forum 2024 at Vizag from December 12th to 14th 2024.

Key Highlights of the Program

a. To Explore Innovation in Healthcare.
b. To Create Public Private Partnerships Platform.
c. To Support Policy-Making in Healthcare
d. To Impact Global Health.

To explore the transformative learning, unparalleled networking opportunities and collaborative initiatives please click the link https://www.whif.kiht.in/registration/ and register for the program.

For additional details on the program, please contact:
Email : whif@kiht.in
Phone: +91 8341622261

Click here for Program Agenda

Source: https://www.whif.kiht.in/

Industry Update – Approval of Bio-Ride scheme by the Cabinet

Posted on by Leave a comment

Cabinet approves ‘Bio-RIDE’ scheme to support Research and Development in Biotechnology

The Cabinet of India has approved the Bio-RIDE scheme, a significant initiative aimed at enhancing research and development in biotechnology. Here are the detailed points regarding this new scheme:

Overview of the Bio-RIDE Scheme

Continuation and Merger: The Bio-RIDE scheme merges two existing umbrella schemes of the Department of Biotechnology (DBT) into one comprehensive initiative, incorporating a new component focused on Biomanufacturing and Biofoundry.

Financial Outlay: The total proposed budget for the implementation of Bio-RIDE is ₹9,197 crore, covering the period from 2021-22 to 2025-26.

Key Components

The Bio-RIDE scheme consists of three main components:

1. Biotechnology Research and Development (R&D): Focuses on advancing research initiatives in
biotechnology

2. Industrial & Entrepreneurship Development (I&ED): Aims to foster industrial growth and entrepreneurship
within the biotechnology sector

3. Biomanufacturing and Biofoundry: Introduces a new focus on sustainable manufacturing practices in
biotechnology.

Objectives and Goals
Fostering Innovation: The scheme aims to accelerate innovation by providing grants and incentives for cutting-edge research in areas such as synthetic biology, bio-pharmaceuticals, bioenergy, and bioplastics.

Promoting Bio-Entrepreneurship: It seeks to create a supportive ecosystem for startups through seed funding, incubation support, and mentorship.

Enhancing Collaboration: Bio-RIDE will facilitate partnerships between academic institutions, research organizations, and industry to enhance the commercialization of bio-based products.

Sustainable Practices: There is a strong emphasis on promoting environmentally sustainable biomanufacturing practices aligned with India’s green goals.

Extramural Funding Support: The scheme will provide extramural funding to research institutions, universities, and individual researchers across various fields including agriculture, healthcare, bioenergy, and environmental sustainability.

Human Resource Development: It includes initiatives for holistic development of students, young researchers, and scientists in biotechnology to build a skilled workforce capable of leveraging technological advancements.

Alignment with National Goals :
The Bio-RIDE scheme is part of India’s broader vision to establish a circular bioeconomy and contribute to climate change mitigation. It aligns with the “Lifestyle for the Environment (LiFE)” initiative launched by the Prime Minister, promoting environmentally friendly solutions across various sectors.

The DBT’s ongoing efforts aim to position India as a global leader in biotechnology research and innovation, with aspirations of achieving a $300 billion bioeconomy by 2030. The Bio-RIDE scheme is expected to play a crucial role in realizing the vision of “Viksit Bharat 2047,” which focuses on comprehensive national development through advanced biotechnology solutions

Source: https://www.pmindia.gov.in/en/news_updates/cabinet-approves-bio-ride-scheme-to-support-cutting-edge-research-and-development-in-biotechnology/

Industry Updates – MCA Notification Amendment Order – MSME

Posted on by Leave a comment

Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Amendment Order, 2024 – MINISTRY OF CORPORATE AFFAIRS Notification

On July 15, 2024, the Ministry of Corporate Affairs issued an amendment to the Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Order, 2019, namely Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Amendment Order, 2024

Objectives

The amendment aims to improve transparency and accountability in corporate payments to micro and small enterprises, ensuring they receive timely payments essential for their operations and growth. This initiative helps protect the interests of smaller suppliers within the business landscape.

Summary of the Amendment

Title: Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Amendment Order, 2024.

Effective Date: The amendment takes effect immediately upon publication in the Official Gazette.

Reporting Criteria: Only specified companies with payments pending to micro or small enterprises for more than 45 days from the acceptance date of goods or services must report this information using MSME Form-1.

Form Update: The existing MSME Form-1 has been replaced with a new form to better capture details about overdue payments.

Click here to read the Notification

Source: https://www.mca.gov.in/bin/ebook/dms/getdocument?doc=NDU5OTY2Mjky&docCategory=Notifications&type=open

Guidance on Auditing Climate Change issues in ISO 9001

Posted on by Leave a comment

Guidance on Auditing Climate Change issues in ISO 9001

Climate change issues are one of many issues that organizations are to consider when analysing their internal and external context and determining requirements from customers and other relevant interested parties.

As part of ISO’s commitment to action on climate change, amendments to over 30 of ISO’s Management System Standards, including ISO 9001, have now been issued to include climate change considerations and the same is published on 23 February 2024.

Key points are given below:

The amendments include the determination of whether climate change is a relevant issue for the organization and the consideration of interested parties’ requirements related to climate change.

Emphasizes the need for auditors to maintain objectivity and neutrality when auditing climate change issues, focusing on assessing how organizations address climate change within their quality management systems

Provides guidance for auditing climate change issues impacting the quality management system and its intended results, outlining specific considerations and examples for auditors to evaluate

Furthermore, the document highlights the importance of addressing issues determined as relevant by the organization within the quality management system.

Presents non-exhaustive examples of questions and related aspects for auditors to assess how organizations are addressing climate change issues, including determining the scope of the quality management system, actions to address risks and opportunities, changes, resources, operations, and performance evaluation and improvement.

Underscores the need for auditors to evaluate if organisations have identified contractually agreed customer requirements or statutory and regulatory requqirements with climate change relevance and whether these are being acted upon.

Click here to read the document

Source: https://committee.iso.org/home/tc176/iso-9001-auditing-practices-group.html

CDSCO mandates online safety reporting

Posted on by Leave a comment

CDSCO mandates online safety reporting for Medical Devices

Following pharmaceuticals, the Central Drugs Standard Control Organisation (CDSCO) has mandated that manufacturers of medical devices and in-vitro devices submit their safety reports online.

The Drugs Controller General of India, has issued the directive on 19th March 2024 for online submission of Period Safety Update Reports for Medical Devices and in-vitro devices, aimed at improving post-market surveillance data evaluation

Effective 1 April 2024, the option to submit applications offline in hard copy or any other method will no longer be available

A PSUR is a vital pharmacovigilance document that assesses the risk-benefit balance of a drug product after its authorization, providing a comprehensive analysis based on all available information, including new data.
This report determines whether additional studies are necessary or if modifications are needed

This is part of efforts to overhaul India’s drug regulation framework and enhance safety transparency.

Click here to read the Circular

Source: https://cdsco.gov.in/opencms/opencms/en/Latest-Circulars/
https://www.livemint.com/

Launch of Indian Foundation for Quality Management

Posted on by Leave a comment

Launch of Indian Foundation for Quality Management

A consortium of seven leading Indian companies have launched the Indian Foundation for Quality Management (IFQM), a Section 8 not-for-profit Company. IFQM is a unique institute dedicated to fostering a culture of quality and innovation within Indian businesses.

The initiative spearheaded by India Inc. viz. Tata Sons, TVS Motor Company, Sun Pharma, Motherson Group, Bharat Forge, Boeing India, and Biocon aims to propel the “Make in India” brand on the global stage.

IFQM will endeavour to equip business leaders with the latest knowledge and tools in quality management, connecting them to renowned global experts for personalized guidance, and facilitating knowledge sharing and collaboration among industry leaders. IFQM will provide support to organisations with specialized quality counsellors  and bridge the gap between industry and academia to ensure access to cutting-edge research and insights.

IFQM’s governing council members besides Venu Srinivasan, N Chandrasekaran, and Dilip Shanghvi will include Kiran Mazumdar Shaw, Baba Kalyani. T.V. Narendran, Vivek Chaand Sehgal, Salil Gupte and K.N. Radhakrishnan.

These founding members will be actively involved in IFQM’s governance ensuring its programs are tailored to the specific needs of Indian businesses. IFQM is designed to provide senior leadership in India with targeted counselling, training, coaching, and expert guidance.

The one-of-its-kind industry-led initiative will help improve the product and service quality and reliability of Indian businesses equipping them to compete more effectively on the global stage and build supply chain resilience. The aim is to reinforce the “Made in India” brand in international markets, thereby stimulating trade expansion.

Enhanced competitiveness will lead to economic growth and overall prosperity for the people of India.

Source: https://www.autocarpro.in/news/import-dependency-for-natural-gas-consumption-expected-at-around-45-by-fy26-careedge-ratings-119688

Smart Hospitals 2024 Conference – Industry Update

Posted on by Leave a comment

Smart Hospitals Conference 2024 @ Mumbai on
15th March 2024

Smart Hospitals Platform is created to help Business Owners of Small and Midsized Hospitals, Daycare Centers, Clinics etc. LEARN to MANAGE their businesses, in alignment with changing market needs and business scenarios.

Conference this year is designed to create conversations on Growth Opportunities for Healthcare Businesses and Investments the sector is attracting over last few years.

Conference Theme :

Indian Healthcare Services – A Decade Of GROWTH 🡅 Forecast
– SMART GROWTH Enablers

𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗢𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲 :

A Decade Of Growth Forecast For Healthcare

Indian Healthcare Space has been witnessing a strong GROWTH surge over the last 2-3 years, especially in Tier 1 and 2 Cities in the country. Demand for Quality Healthcare is on the rise and this market need is driving heavy flow of Private Equity Investments into the sector over the last 2-3 years.

Industry Reports say in Indian metros total bed density remains largely uncapitalised and for Quality beds there is a demand-supply gap of 20-30 per cent. 

Tier 1 and 2 cities are where a large part of India’s GDP growth is going to happen and they will become a very important growth engine of this healthcare market. Providers of Services prefer to be in the markets where the market needs are not met.

Indian Healthcare Services – 5 Strong Pillars of Growth

Services Growth will be driven by the Convergence of following sub domains providing care delivery through multiple channels :

– Hospitals
– Home Care
– Diagnostics
– Health Insurance
– Digital Health

ENABLERS for GROWTH for each sub domain may vary . SMART Hospitals Conference will have  speakers discussing about the much needed ENABLERS to Drive the Growth.

Opportunity for Healthcare Service Providers across the spectrum from Tier 1,2,3,4 and 5 cities to join the session and Listen to Experts Opinions, Views on the SMART Growth Enablers that will drive the Sectoral Growth over the next decade. 

𝗪𝗵𝗲𝗻 ?

📅 Date: 15th March 2024 – Friday
⏲ Time: 10 00 am – 5 00 pm
🌆 Venue: Bombay Exhibition Centre, Mumbai

𝗪𝗵𝗼 𝗦𝗵𝗼𝘂𝗹𝗱 𝗔𝘁𝘁𝗲𝗻𝗱 ?

Promoters of Hospitals / Other Healthcare Service Organizations (Micro, Small, Medium and Large  Organizations) ,   Medical Professionals / Practitioners ,  Administrators, Management / Operations Teams, Marketing Teams, Managerial Teams, Technology Teams , Startups, Innovators,  HealthTech, MedTech, Digital Health Companies , Investors , Academic Institutions , Innovators, Nursing Professionals, Paramedical Teams, Health Insurers, TPAs, Management Consultants, Finance Professionals and other stakeholders

Download Program Brochure
Download Program Agenda

Conference Entry by prior registration.

Delegate Fee:

INR 1000 (including GST) per Participant. Fee includes Lunch & Hi Tea arrangements

𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 :

𝗦𝘁𝗲𝗽 𝟭 :

Make the payment using the QR code shared below 

𝗦𝘁𝗲𝗽 𝟮 :

Click the ‘Register here” button given below and fill up the delegate registration form. Please mention the payment reference number in the form 

Register here

For detailed information about Expo, Conference , click : https://www.medicalfair-india.com/special-shows-overview

For enquiries related to Conference Partnerships, Stalls booking inside Diagnostics Pavilion , delegate registration enquiries, pls write to :

VermaA@md-india.com / +91-124-4544507
Ms Rama Venugopal – info@events.healthcare / +91 9840870532

For conference delegate registration enquiries, please write to :
Ms Rama Venugopal – info@events.healthcare / +91 9840870532

Source: https://smarthospitals.events/

Clinlab India 2024 Conference – Industry Update

Posted on by Leave a comment

CLIN LAB INDIA 2024 CONFERENCE @Mumbai on
14th March 2024

MEDICAL FAIR INDIA is India’s leading Trade Fair for the Medical and Healthcare Industry. For the last 28 years, Medical Fair India has been successfully addressing the various needs of Hospitals, Health Centres & Clinics.  With participation from over 20 countries, MEDICAL FAIR INDIA provides an opportunity to position your brand among competitors and further increase your level of visibility. MEDICAL FAIR INDIA acts as a platform where connections are made and business relationships are nurtured.

ClinLab India is the exhibition & conference on the topic of laboratory medicine, Point of Care Testing, molecular diagnostics and clinical chemistry. The show is aimed to promote the recent developments and market trends in the in-vitro diagnostics (IVD) sector and allied areas.

ClinLab India brings together the leaders in the medical laboratory industry designed to create maximum interaction and meeting opportunities where manufacturers, dealers and distributors can promote their brands, meet potential customers and entertain existing clients. 

The year 2024 holds a lot of promise for the Indian IVD industry. Technology is also going to be a critical growth factor. The Indian start-up ecosystem is aggressively targeting the IVD-MedTech segment, and we will see some compelling solutions from them soon

This is the 5th Edition of ClinLab India.

Conference Theme 2024 :
Driving Global Dominance through Innovations :
– IVD Industry’s Role in Economic Growth

𝗪𝗵𝗲𝗻 ?
📅 Date: 14th March 2024 – Thursday
⏲ Time: 10 00 am – 5 00 pm
🌆 Venue: Bombay Exhibition Centre, Mumbai

𝗪𝗵𝗼 𝗦𝗵𝗼𝘂𝗹𝗱 𝗔𝘁𝘁𝗲𝗻𝗱 ?

IVD , Biotech companies – Management & Technical Personnel, Healthcare Services – Management & Technical Teams from Clinical Labs/Hospitals/Blood Banks/CROs/Medical Colleges/Home Healthcare Companies and Other Healthcare Organisations , Startups, Innovators from Biotech space, Other stakeholders, Government Representatives

𝐅𝐨𝐫 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐔𝐩𝐝𝐚𝐭𝐞𝐬, please visit :

https://www.medicalfair-india.com/special-shows-clin-lab-india

Download Clinlab Conference Brochure
Download Clinlab Conference Agenda

Conference Entry by Prior Registration.

Delegate Fee : INR 1100 per participant (including GST). Fee includes Lunch & Hi Tea

𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 :

𝗦𝘁𝗲𝗽 𝟭 :

Make the payment using the QR code shared below

Step 2:
Click the ‘Register here” button given below and fill up the delegate registration form. Please mention the payment reference number in the form 

Register here

For more information about Expo, visit : https://www.medicalfair-india.com

For enquiries related to Conference Partnerships, Stalls booking inside Diagnostics Pavilion , delegate registration enquiries, pls write to :

VermaA@md-india.com / +91-124-4544507
Ms Rama Venugopal – info@events.healthcare / +91 9840870532

For conference delegate registration enquiries, please write to :
Ms Rama Venugopal – info@events.healthcare / +91 9840870532

Source: https://events.healthcare/

Share